comprehensive, and coordinated care, and many individuals with substance-related issues seek primary care because they are dealing with medical conditions related to or complicated by their substance use. [20] [21] [22] However, despite the feasibility and potential for primary care to increase access to treatment, few primary care settings offer treatment for OAUD. 23 Implementing evidence-based treatments for SUDs in primary care is considered a key strategy for increasing access and decreasing unmet need. The Patient Protection and Affordable
Care Act and the Mental Health Parity and Addiction Equity
Act decreased financial barriers to access and designated SUD treatment as an essential health benefit. 24, 25 Additionally, the National Drug Control Strategy recommends that Federally
Qualified Health Centers (FQHCs) substantially expand their delivery of SUD treatment services. 26 The chronic care model addresses the need to transform the way clinical care is delivered for chronic illnesses and has been applied to both medical and mental health conditions, but has not been applied to OAUD treatment in primary care, 27, 28 despite the similarity of OAUD with other chronic illnesses. 27, 29 Additionally, although robust evidence demonstrates the effectiveness of the model for improving both care processes and clinical outcomes, 30 there is little information about how to operationalize it for diverse chronic conditions such as OAUD.
Several studies have applied the principles of chronic care management to the treatment of SUDs. The AHEAD trial 31 tested the impact of chronic care management delivered in a part-time addiction medicine clinic, and a recent trial for homeless women used care managers to refer patients from primary care to specialty SUD care 32 ; neither found that the chronic care management intervention impacted outcomes.
However, neither of these trials implemented the chronic care model as originally conceptualized, 28 as neither integrated OAUD treatment with the patient's usual primary care, or addressed how the primary care system could be transformed to provide evidence-based treatment for OAUD delivered by a patient's usual providers.
This paper describes the process and outcome of a collaborative planning and development process used by researchers and community providers to apply the chronic care model to the delivery of treatment for OAUD in primary care. Food and Drug Administration, making them feasible and appropriate for treatment within primary care. 33, 34 The clinical intervention is being tested in a randomized controlled trial, currently underway. 35 The study was approved by the RAND Human Subjects Protection Committee.
PArtnershiP And setting
The partnership for the collaborative planning process included researchers, staff, and providers at a multisite FQHC APPlicAtion of the chronic cAre Model to the delivery of oAUd cAre
The chronic care model is a framework that guides health care delivery systems-particularly primary care practices-to translate general ideas for quality improvement into specific applications. 28 The model posits that, to improve health outcomes, the health care system needs to consider six elements of care, which have been shown in previous studies to improve outcomes. Throughout the first 18 months of the collaborative planning process, the partnership considered how these six elements could be applied to the treatment of OAUDs within the context of a FQHC. Each element was framed as a question, which guided the work of the partnership (Table 1) .
collAborAtive PlAnning And develoPMent Process [36] [37] [38] [39] [40] [41] [42] In parallel with the process used to identify and address implementation barriers, the team developed current and future state workflow diagrams and draft care protocols to allow the organization to visualize how the continuum of care for OAUD could be integrated into clinic practices. Where 
Obtain leadership buy-in for procedural changes (barriers 1, 2, and 3):
Clinic leadership and executive board endorsed program ("part of mission").
Medical assistant training in new OAUD screening protocol.
Clinic leadership authorized extended time for both medical and therapy intake visits.
Leadership authorized the creation of a CC position and revised professional roles.
Organize and hold clinician/researcher implementation team meetings (barriers 1, 2, 3, and 4):
Monthly meetings held to develop and implement screening protocol.
Monthly meetings held to develop a written care protocol with detailed specifications of who does what to whom, when and how.
Revise professional roles (barrier 2):
Protocol included a new position, the CC, who used a registry to track and follow patients identified with OAUDs, and who functioned as a link between the BHP and primary care providers.
Researcher/clinician implementation team considered how CC, therapist and medical provider would work together, and what tasks could be shifted away from medical provider.
Conduct cyclical small tests of change (barriers 1 and 2):
Care protocol was iteratively tested and refined during a pilot phase before formal testing, using the plan-do-study-act method.
Medical assistants screen all patients at every visit using a validated screener. 
Develop and distribute educational materials (barrier 1):
Researchers and clinic staff partnered to create written educational materials in English and Spanish appropriate for clinic population; materials reviewed by patients and revised.
CCs provide patients with written educational materials at time of initial contact.
BHPs and medical providers educate patients about different treatment options (BT, MAT, detoxification, watchful waiting) at intake and, if needed, at subsequent visits.
Encourage patients to initiate and engage with treatment (barriers 2 and 3):
CCs meet with patients and, using motivational interviewing techniques, attempt to engage patients with care.
Registry prompts CCs to call patients and offer multiple opportunities to engage with treatment.
CCs assess clinical status and patient goals bi-weekly using standardized questionnaire; data entered into registry along with urine toxicology results.
Registry creates an individualized patient report which provides visual feedback to patient on their goals and progress.
Educational materials made available to all patients identified with a OAUD.
Posters placed throughout clinic to encourage patients to seek help for their substance use.
Patients given multiple opportunities to access different types of treatment.
Prompted by registry, CC made reminder phone calls.
Individualized patient reports showing progress and goals given to patient.
CC trained in motivational interviewing techniques during a 2-day training and used techniques to validate patients' current readiness to change and encourage patients to try "one visit" to see if BT was a good fit.
BT, brief treatment; BHP, behavioral health provider; CC, Care Coordinator; MAT, medication-assisted treatment; OAUD, opioid and/or alcohol use disorder.
ensure they were consistent with the best available science. Tables 2 through 6 The end product of the collaborative planning process was a clinical intervention, Collaborative Care (CC) 45, 46 (Table   7 3. MAT and BT treatment protocols not specific for primary care.
oUtcoMes of the collAborAtive PlAnning Process

Conduct a local needs assessment (barriers 1 and 2):
Researchers and clinic staff conducted a local needs assessment to assess provider readiness to deliver OAUD care.
Adapt existing treatment protocols to meet local needs while maintaining fidelity (barriers 2 and 3):
Multidisciplinary research/clinician team with MAT and MI expertise adapted existing treatment manuals and developed treatment protocols for primary care setting.
Final treatment protocols were reviewed by at least two external experts to identify if recommendations were consistent with best practices.
Identify and prepare champions (barriers 1 and 2):
Two champions (one medical and one behavioral health) came forward and began to use the two treatment protocols. Their experiences were shared with other clinicians, informally in conversations and formally in staff meetings.
Provide training and technical assistance (barriers 1 and 2):
Brought in local addiction experts to provide training to all staff on the impact of substance use disorders on health of patients.
Facilitate providers obtaining needed DEA certification.
Conduct cyclical small tests of change (barriers 1 and 3):
Champions and staff tried out different steps in the process and team made real-time changes to procedures based on user feedback.
Purposely examine treatment protocols during pilot test for feasibility and acceptability (barriers 1, 2, and 3):
Protocols iteratively tried out and refined.
Feedback from all providers explicitly encouraged and incorporated into final protocols.
Care protocol and pilot test allowed providers to visualize how treatment could work in their system.
Provide ongoing clinical supervision (barriers 1 and 2):
Local addiction experts provided ongoing supervision and consultation.
Medical providers trained in MAT and have DEA certification to prescribe buprenorphine.
Provision of ongoing, OAUDspecific decision support for medical providers.
Two-day training in BT for both the BHP and the CC, followed by weekly supervision/case management meetings attended by BHP and CC.
Providers behaviorally and psychologically ready to integrate OAUD treatment, demonstrated by provider adoption of BT and MAT into routine practice.
MAT and BT treatment protocols created for primary care.
BT, brief treatment; BHP, behavioral health provider; CC, Care Coordinator; MAT, medication-assisted treatment; MI, motivational interviewing; OAUD, opioid and/or alcohol use disorder. 
Develop and implement stand-alone registry for population-based management:
Researchers and clinical champions partnered to describe how the registry would be used and determined the registry could not be part of the EHR.
Researchers created registry.
CCs given access to registry and then they iteratively tested and provided feedback on ease of use and functionality.
Registry prompts CCs to make reminder phone calls to patients 2 days before each therapy appointment, assess outcomes on all patients attending BT using a validated clinical outcomes monitoring tool, and order monthly urine toxicology screens.
Registry was used by CCs to generate a list of all patients for population-based tracking during bi-weekly clinical supervision meetings attended by BHPs and CCs; Information from registry was relayed to medical providers by CCs through the EHR.
Registry prompts CCs to call out-of-treatment patients and offer patients multiple opportunities to engage with treatment.
Revise the EHR system:
EHR alert placed on chart so that medical providers know to ask patient about substance use and desire for treatment at initial and subsequent visits.
Population-based tracking of all patients identified with OAUDs in bi-weekly meetings attended by CC and BHPs.
Measurement-based care for all patients receiving treatment for OAUDs.
Medical providers able to access information collected by CCs on patient's clinical status.
BHP, behavioral health provider; CC, care coordinator; EHR, electronic health record; OAUD, opioid and/or alcohol use disorder. 2. Linkage with community resources used infrequently.
Created community linkages (barrier 2):
Visited local specialty substance use treatment provider to build working relationships and develop referral processes for clinic patients.
Obtain formal commitments (barrier 1):
Obtained commitment from provider of inpatient detoxification services to expedite access to services.
Developed mutually agreed-upon protocol for patient referral.
Promote network weaving (barriers 1 and 2):
Lists of available community resources, including AA/ NA and specialty providers developed and provided to patients by CC.
Patients referred to a more intensive level of care if provider and patient together determine that this level of care is insufficient.
Patients able to access inpatient detoxification services without long waiting periods.
Patients able to access a higher level of care if needed.
system and general medical care, and the difficulties inherent in creating the organizational changes needed to implement any new practice. 40, 48 In this article, we describe a process conflicting And coMPeting interests
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